文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

来自[具体来源]的口服胶囊的开发与体外评价:一种用于周围神经病变的便捷替代物

Development and In Vitro Evaluation of Oral Capsules from : A Convenient Substitute for Peripheral Neuropathy.

作者信息

Archer Mary-Ann, Kumadoh Doris, Gaizer Samuel Nii-Bortier, Mensah Adelaide, Jato Jonathan, Kyene Micheal Odoi, Mintah Susana Oteng, Yeboah Genevieve Naana, Sodzi Paul Kwesi, Adi-Dako Ofosua

机构信息

Department of Pharmaceutics, University of Cape Coast, Cape Coast, Ghana.

Department of Drug Production and Quality Assurance, West African Postgraduate College of Pharmacist, Accra, Ghana.

出版信息

Adv Pharmacol Pharm Sci. 2022 Apr 27;2022:5340953. doi: 10.1155/2022/5340953. eCollection 2022.


DOI:10.1155/2022/5340953
PMID:35528114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9068321/
Abstract

is a monoherbal decoction produced by the Centre for Plant Medicine Research (CPMR), Mampong-Akuapem, Ghana. It is prepared from the stem bark of Engl. (Moraceae), prescribed, and dispensed to patients for the management of nervous disorders. This current formulation presents notable challenges in patients' adherence to treatment regimen due to its bulkiness and bitterness. These challenges have resulted in a decrease in therapeutic outcome. This study sought to transform into oral capsules to mask its bitter taste and reduce bulkiness of the product to improve patients' convenience. In this study, four (4) conventional release capsule formulations were successfully prepared from the decoction via wet granulation using corn starch, lactose, light magnesium carbonate (LMC), and microcrystalline cellulose (MCC) and labelled A01, A02, A03, and A04 respectively. The drug-excipient compatibility studies on A01, A02, A03, and A04 were investigated using Fourier transform infrared (FTIR) spectroscopy. The flow properties of the granules as well as the quality assessment of the formulations such as dissolution, disintegration, uniformity of weight, and assay tests were evaluated using pharmacopoeial and nonpharmacopoeial methods. Appropriate models were used to investigate the difference factor ( ) and similarity factor ( ) of the dissolution profiles of the formulations and . From the study, all formulated granules had excellent flow properties with Carr's index from 7.83 to 9.56%, Hausner's ratio from 1.09 to 1.10, and angle of repose from 25.13 to 27.87°. Drug-excipient compatibility studies demonstrated no interaction between extract and used excipients. All formulations passed the uniformity of weight, disintegration, assay, and dissolution tests. Formulation A02 had the highest dissolution efficiency of 100.12%, while A03 recorded the least value of 97.22% in the 1 h dissolution studies. A comparison of their various dissolution profiles, respectively, to that of its decoction demonstrated their similarity, since, in all comparisons,  < 15 and  > 50. This implies that, any of these four formulations could be a good substitute for .

摘要

是一种由加纳曼蓬 - 阿夸佩姆植物医学研究中心(CPMR)生产的单味草药煎剂。它由桑科植物英格氏(Engl.)的茎皮制备而成,按规定调配并分发给患者用于治疗神经紊乱。由于其体积大且味苦,目前这种制剂在患者坚持治疗方案方面存在显著挑战。这些挑战导致治疗效果下降。本研究旨在将其转化为口服胶囊,以掩盖其苦味并减小产品体积,提高患者的便利性。在本研究中,通过湿法制粒,使用玉米淀粉、乳糖、轻质碳酸镁(LMC)和微晶纤维素(MCC),从煎剂中成功制备了四种(4)普通释放胶囊制剂,分别标记为A01、A02、A03和A04。使用傅里叶变换红外(FTIR)光谱对A01、A02、A03和A04进行药物 - 辅料相容性研究。使用药典和非药典方法评估颗粒的流动性以及制剂的质量评估,如溶出度、崩解度、重量均匀度和含量测定试验。使用适当的模型研究制剂和的溶出曲线的差异因子()和相似因子()。从研究中可知,所有制备的颗粒具有优异的流动性,卡尔指数为7.83%至9.56%,豪斯纳比为1.09至1.10,休止角为25.13°至27.87°。药物 - 辅料相容性研究表明提取物与所用辅料之间无相互作用。所有制剂均通过了重量均匀度、崩解度测定、含量测定和溶出度试验。在1小时溶出度研究中,制剂A02的溶出效率最高,为100.12%,而A03记录的值最低,为97.22%。将它们各自的各种溶出曲线与其煎剂的溶出曲线进行比较,表明它们具有相似性,因为在所有比较中,<15且>50。这意味着这四种制剂中的任何一种都可以很好地替代。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/0380001f5599/APS2022-5340953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/e9fa2bcc49a8/APS2022-5340953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/87445fe0612e/APS2022-5340953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/c3416b8a0640/APS2022-5340953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/e3d8551b0643/APS2022-5340953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/0380001f5599/APS2022-5340953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/e9fa2bcc49a8/APS2022-5340953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/87445fe0612e/APS2022-5340953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/c3416b8a0640/APS2022-5340953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/e3d8551b0643/APS2022-5340953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe6/9068321/0380001f5599/APS2022-5340953.005.jpg

相似文献

[1]
Development and In Vitro Evaluation of Oral Capsules from : A Convenient Substitute for Peripheral Neuropathy.

Adv Pharmacol Pharm Sci. 2022-4-27

[2]
Development of agglomerated directly compressible diluent consisting of brittle and ductile materials.

Pharm Dev Technol. 2003

[3]
Formulation and In Vitro Evaluation of Oral Capsules from Liquid Herbal Antimalarials Marketed in Ghana.

J Trop Med. 2021-1-18

[4]
Development of co-processed excipients in the design and evaluation of atorvastatin calcium tablets by direct compression method.

Int J Pharm Investig. 2014-4

[5]
Exploring the potential of natural polymers from plants as tablet binder and accessing their release profiles: A comparative analysis.

Pak J Pharm Sci. 2023-9

[6]
A cross-performance relationship between Carr's index and dissolution rate constant: the study of acetaminophen batches.

Drug Dev Ind Pharm. 2007-11

[7]
Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin.

Indian J Pharm Sci. 2015

[8]
Oral Disintegration Tablets of Stavudine for HIV Management: A New Technological Approach.

Indian J Pharm Sci. 2012-11

[9]
Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations.

Pak J Pharm Sci. 2015-5

[10]
Isolation, characterization and investigation of Cordia dichotoma fruit polysaccharide as a herbal excipient.

Int J Biol Macromol. 2015-1

引用本文的文献

[1]
Rech. f. & Esfand as adjunctive therapy for eradication: a randomized controlled trial.

J Tradit Chin Med. 2025-4

[2]
Evaluation of packaging, labels, and some physicochemical properties of herbal antimalarial products on the Ghanaian market.

Heliyon. 2024-2-28

本文引用的文献

[1]
Formulation and In Vitro Evaluation of Oral Capsules and Suspension from the Ethanolic Extract of Seeds for the Treatment of Diarrhea.

Biomed Res Int. 2021

[2]
Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana.

ScientificWorldJournal. 2021

[3]
Safety and Effectiveness of , a Herbal Preparation for Treatment of Peripheral Neuropathy.

Biomed Res Int. 2019-7-24

[4]
A first-principles model for prediction of product dose uniformity based on drug substance particle size distribution.

J Pharm Sci. 2012-4-13

[5]
Reliability of the neurological scores for assessment of sensorimotor neuropathy in type 2 diabetics.

J Pak Med Assoc. 2010-3

[6]
Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.

Int J Pharm. 2008-9-1

[7]
Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tablet.

Eur J Pharm Sci. 2004-7

[8]
An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles.

J Pharm Biomed Anal. 1998-8

[9]
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Pharm Res. 1995-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索